Stocksigma LogoStocksigma Logo

Brawn Biotech Claims Exemption from SEBI RPT Disclosure Regulations

Brawn Biotech submitted an undertaking regarding the non-applicability of Related Party Transactions (RPT) filing under Regulation 23(9) of SEBI LODR

Brawn Biotech Claims Exemption from SEBI RPT Disclosure Regulations

Brawn Biotech Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 9:59 pm

Brawn Biotech Claims Exemption from SEBI RPT Disclosure Regulations Brawn Biotech submitted an undertaking regarding the non-applicability of Related Party Transactions (RPT) filing under Regulation 23(9) of SEBI LODR Regulations for the quarter ended Sep'26. As of 31st Mar'26, the company reported a paid-up share capital of Rs. 3 Cr and a net worth of approximately Rs. 4.32 Cr. Both metrics have remained below the regulatory exemption thresholds of Rs. 10 Cr and Rs. 25 Cr, respectively, for the last three consecutive financial years pursuant to Regulation 15(2).

Original exchange filing (PDF)

More announcements from Brawn Biotech Ltd

All Brawn Biotech Ltd announcements